Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Holders of 5% or more of PBH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Prestige Consumer Healthcare Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.20%7.52M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| Ariel Investments, LLC | 13G/A | 8.50%4.10M shares | +1.20 ppfrom 7.30% | Aug 13, 20253 filings | Feb 13, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.97%2.83M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Dimensional Fund Advisors LP | 13G/A | 5.90%2.91M shares | – | Jan 23, 20251 filing | Jan 23, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.18%2.45M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Prestige Consumer Healthcare Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 202612:13 PM ET | Vanguard Capital Management LLC | 13G | 5.18%2.45M shares | New | Mar 31, 2026 | SEC |
| Apr 29, 20262:51 PM ET | Vanguard Portfolio Management LLC | 13G | 5.97%2.83M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202611:21 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 13, 202610:52 AM ET | Ariel Investments, LLC | 13G/A | 8.50%4.10M shares | +1.20 ppfrom 7.30% | Dec 31, 2025 | SEC |
| Nov 14, 202511:24 AM ET | Ariel Investments, LLC | 13G | 7.30%3.59M shares | +2.80 ppfrom 4.50% | Sep 30, 2025 | SEC |
| Aug 13, 20254:14 PM ET | Ariel Investments, LLC | 13G/A | 4.50%2.20M shares | –Below 5% | Jun 30, 2025 | SEC |
| Apr 30, 20259:25 AM ET | BlackRock, Inc. | 13G/A | 15.20%7.52M shares | – | Mar 31, 2025 | SEC |
| Feb 7, 20257:43 AM ET | Macquarie Group Ltdand 2 others | 13G/A | 4.67%2.31M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 23, 20253:55 PM ET | Dimensional Fund Advisors LP | 13G/A | 5.90%2.91M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Prestige Consumer Healthcare Inc. shares.
No Form 144 notices for Prestige Consumer Healthcare Inc. are on file.